KENNAH BREARLEY: Open Payments
NPI 1285979435 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,186 in 90 payments from 15 companies in 2025. Trend: 2023 $181 · 2024 $890 · 2025 $2,186
Food & beverage: $2,091Education: $95
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $408 |
| Janssen Biotech, Inc. | 11 | $299 |
| GENZYME CORPORATION | 11 | $278 |
| Galderma Laboratories, L.P. | 12 | $263 |
| Regeneron Healthcare Solutions, Inc. | 12 | $234 |
| Amgen Inc. | 11 | $177 |
| Novartis Pharmaceuticals Corporation | 6 | $128 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $95 |
| Lilly USA, LLC | 4 | $83 |
| Incyte Corporation | 2 | $53 |
Products named: DUPIXENT, Bimzelx, TREMFYA, NEMLUVIO, OTEZLA, COSENTYX, TALTZ, OPZELURA.
Industry payments across SC — which companies pay providers there.
